1-14 of 14
Dennis J. Ahnen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4584: VDR genotype modifies vitamin D efficacy for colorectal adenoma prevention in a randomized controlled trial

Elizabeth L. Barry, Leila A. Mott, Judith R. Rees, Dennis J. Ahnen, Roberd M. Bostick, Robert S. Bresalier, Douglas J. Robertson, Robert W. Summers, John A. Baron
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4584.
https://doi.org/10.1158/1538-7445.AM2015-4584
Published: 01 August 2015
View article titled, Abstract 4584: VDR genotype modifies vitamin D efficacy for colorectal adenoma prevention in a randomized controlled trial
Journal Articles

Abstract CT335: A clinical trial of supplementation with vitamin D and/or calcium for the prevention of colorectal adenomas

John A. Baron, Elizabeth L. Barry, Dennis J. Ahnen, Carol A. Burke, Roberd M. Bostick, Robert S. Bresalier, Timothy R. Church, Marcia Cruz-Correa, Michael Goodman, Robert Haile, Anastasia Ivanova, Richard I. Rothstein, Robert S. Sandler, Dale Snover, Robert W. Summers
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT335.
https://doi.org/10.1158/1538-7445.AM2014-CT335
Published: 01 October 2014
View article titled, Abstract CT335: A clinical trial of supplementation with vitamin D and/or calcium for the prevention of colorectal adenomas
Journal Articles

Abstract 2831: Ornithine decarboxylase polymorphisms and risk of colorectal adenoma

Elizabeth L. Barry, Leila A. Mott, Robert S. Sandler, Dennis J. Ahnen, John A. Baron
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2831.
https://doi.org/10.1158/1538-7445.AM10-2831
Published: 15 April 2010
View article titled, Abstract 2831: Ornithine decarboxylase polymorphisms and risk of colorectal adenoma
Journal Articles

Abstract LB-142: Marked efficacy of difluoromethylornithine plus sulindac in reducing recurrent colorectal adenomas in patients with prior adenomas: Results of a randomized, placebo-controlled, double-blind Phase III trial.

Frank L. Meyskens, Jr., Eugene W Gerner, Daniel Pelot, Philip M Carpenter, Christine E. McLaren, Sharon Fujikawa-Brooks, Michael Lawson, Jayashri Kidao, John McCracken, Gregory Albers, Dennis J Ahnen, Kim Turgeon
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): LB-142.
https://doi.org/10.1158/1538-7445.AM2008-LB-142
Published: 15 May 2008
View article titled, Abstract LB-142: Marked efficacy of difluoromethylornithine plus sulindac in reducing recurrent colorectal adenomas in patients with prior adenomas: Results of a randomized, placebo-controlled, double-blind Phase III trial.
Journal Articles

A randomized trial of folic acid to prevent colorectal adenomas

Bernard F. Cole, John A. Baron, Robert S. Sandler, Robert W. Haile, Dennis J. Ahnen, Robert S. Bresalier, Gail Mckeown-Eyssen, Robert W. Summers, Richard Rothstein, Carol A. Burke, Dale C. Snover, Timothy R. Church, Tim Byers
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1041.
Published: 01 May 2005
View article titled, A randomized trial of folic acid to prevent colorectal adenomas
Journal Articles

Inhibition of Extracellular-signal Regulated Kinases 1/2 Is Required for Apoptosis of Human Colon Cancer Cells In vitro by Sulindac Metabolites

Pamela L. Rice, K. Scott Beard, Linda J. Driggers, Dennis J. Ahnen
Journal: Cancer Research
Cancer Res (2004) 64 (22): 8148–8151.
https://doi.org/10.1158/0008-5472.CAN-04-1517
Published: 17 November 2004
View article titled, Inhibition of Extracellular-signal Regulated Kinases 1/2 Is Required for Apoptosis of Human Colon Cancer Cells <em>In vitro</em> by Sulindac Metabolites
Open the PDF for Inhibition of Extracellular-signal Regulated Kinases 1/2 Is Required for Apoptosis of Human Colon Cancer Cells <em>In vitro</em> by Sulindac Metabolites in another window
Journal Articles

Sulindac Sulfide Inhibits Epidermal Growth Factor-induced Phosphorylation of Extracellular-regulated Kinase 1/2 and Bad in Human Colon Cancer Cells

Pamela L. Rice, Michele Washington, Shea Schleman, K. Scott Beard, Linda J. Driggers, Dennis J. Ahnen
Journal: Cancer Research
Cancer Res (2003) 63 (3): 616–620.
Published: 01 February 2003
View article titled, Sulindac Sulfide Inhibits Epidermal Growth Factor-induced Phosphorylation of Extracellular-regulated Kinase 1/2 and Bad in Human Colon Cancer Cells
Open the PDF for Sulindac Sulfide Inhibits Epidermal Growth Factor-induced Phosphorylation of Extracellular-regulated Kinase 1/2 and Bad in Human Colon Cancer Cells in another window
Journal Articles

Inhibition of Extracellular Signal-regulated Kinase 1/2 Phosphorylation and Induction of Apoptosis by Sulindac Metabolites

Pamela L. Rice, Ryan J. Goldberg, Evan C. Ray, Linda J. Driggers, Dennis J. Ahnen
Journal: Cancer Research
Cancer Res (2001) 61 (4): 1541–1547.
Published: 02 February 2001
View article titled, Inhibition of Extracellular Signal-regulated Kinase 1/2 Phosphorylation and Induction of Apoptosis by Sulindac Metabolites
Open the PDF for Inhibition of Extracellular Signal-regulated Kinase 1/2 Phosphorylation and Induction of Apoptosis by Sulindac Metabolites in another window
Journal Articles

Risk Factors for Ki-ras Protooncogene Mutation in Sporadic Colorectal Adenomas

María Elena Martínez, Terese Maltzman, James R. Marshall, Janine Einspahr, Mary E. Reid, Richard Sampliner, Dennis J. Ahnen, Stanley R. Hamilton, David S. Alberts
Journal: Cancer Research
Cancer Res (1999) 59 (20): 5181–5185.
Published: 01 October 1999
View article titled, Risk Factors for Ki-<em>ras</em> Protooncogene Mutation in Sporadic Colorectal Adenomas
Open the PDF for Risk Factors for Ki-<em>ras</em> Protooncogene Mutation in Sporadic Colorectal Adenomas in another window
Journal Articles

Ki-ras Mutation and p53 Overexpression Predict the Clinical Behavior of Colorectal Cancer: A Southwest Oncology Group Study

Dennis J. Ahnen, Polly Feigl, Gang Quan, Cecelia Fenoglio-Preiser, Laura C. Lovato, Paul A. Bunn, Jr., Grant Stemmerman, John D. Wells, John S. Macdonald, Frank L. Meyskens, Jr.
Journal: Cancer Research
Cancer Res (1998) 58 (6): 1149–1158.
Published: 01 March 1998
View article titled, Ki-<em>ras</em> Mutation and p53 Overexpression Predict the Clinical Behavior of Colorectal Cancer: A Southwest Oncology Group Study
Open the PDF for Ki-<em>ras</em> Mutation and p53 Overexpression Predict the Clinical Behavior of Colorectal Cancer: A Southwest Oncology Group Study in another window
Journal Articles

Sulindac Sulfone Inhibits Azoxymethane-induced Colon Carcinogenesis in Rats without Reducing Prostaglandin Levels

Gary A. Piazza, David S. Alberts, Lee J. Hixson, Nancy Shipp Paranka, Han Li, Tyler Finn, Cheryl Bogert, Jose M. Guillen, Klaus Brendel, Paul H. Gross, Gerhard Sperl, Justine Ritchie, Randall W. Burt, Lansing Ellsworth, Dennis J. Ahnen, Rifat Pamukcu
Journal: Cancer Research
Cancer Res (1997) 57 (14): 2909–2915.
Published: 01 July 1997
View article titled, Sulindac Sulfone Inhibits Azoxymethane-induced Colon Carcinogenesis in Rats without Reducing Prostaglandin Levels
Open the PDF for Sulindac Sulfone Inhibits Azoxymethane-induced Colon Carcinogenesis in Rats without Reducing Prostaglandin Levels in another window
Journal Articles

Apoptosis Primarily Accounts for the Growth-inhibitory Properties of Sulindac Metabolites and Involves a Mechanism That Is Independent of Cyclooxygenase Inhibition, Cell Cycle Arrest, and p53 Induction

Gary A. Piazza, Alanna K. Rahm, Tyler S. Finn, Benjamin H. Fryer, Han Li, Alan L. Stoumen, Rifat Pamukcu, Dennis J. Ahnen
Journal: Cancer Research
Cancer Res (1997) 57 (12): 2452–2459.
Published: 01 June 1997
View article titled, Apoptosis Primarily Accounts for the Growth-inhibitory Properties of Sulindac Metabolites and Involves a Mechanism That Is Independent of Cyclooxygenase Inhibition, Cell Cycle Arrest, and p53 Induction
Open the PDF for Apoptosis Primarily Accounts for the Growth-inhibitory Properties of Sulindac Metabolites and Involves a Mechanism That Is Independent of Cyclooxygenase Inhibition, Cell Cycle Arrest, and p53 Induction in another window
Journal Articles

Sulfone Metabolite of Sulindac Inhibits Mammary Carcinogenesis

Henry J. Thompson, Cheng Jiang, Junxuan Lu, Rajendra G. Mehta, Gary A. Piazza, Nancy S. Paranka, Rifat Pamukcu, Dennis J. Ahnen
Journal: Cancer Research
Cancer Res (1997) 57 (2): 267–271.
Published: 01 January 1997
View article titled, Sulfone Metabolite of Sulindac Inhibits Mammary Carcinogenesis
Open the PDF for Sulfone Metabolite of Sulindac Inhibits Mammary Carcinogenesis in another window
Journal Articles

Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis

Gary A. Piazza, Alanna L. Kulchak Rahm, Mary Krutzsch, Gerhard Sperl, Nancy Shipp Paranka, Paul H. Gross, Klaus Brendel, Randall W. Burt, David S. Alberts, Rifat Pamukcu, Dennis J. Ahnen
Journal: Cancer Research
Cancer Res (1995) 55 (14): 3110–3116.
Published: 01 July 1995
View article titled, Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis
Open the PDF for Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis in another window